Correlation Between Mangalam Drugs and NCC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and NCC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and NCC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mangalam Drugs And and NCC Limited, you can compare the effects of market volatilities on Mangalam Drugs and NCC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of NCC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and NCC.

Diversification Opportunities for Mangalam Drugs and NCC

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Mangalam and NCC is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and NCC Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NCC Limited and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with NCC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NCC Limited has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and NCC go up and down completely randomly.

Pair Corralation between Mangalam Drugs and NCC

Assuming the 90 days trading horizon Mangalam Drugs And is expected to under-perform the NCC. But the stock apears to be less risky and, when comparing its historical volatility, Mangalam Drugs And is 1.02 times less risky than NCC. The stock trades about -0.14 of its potential returns per unit of risk. The NCC Limited is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  28,450  in NCC Limited on December 26, 2024 and sell it today you would lose (7,977) from holding NCC Limited or give up 28.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Mangalam Drugs And  vs.  NCC Limited

 Performance 
       Timeline  
Mangalam Drugs And 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
NCC Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NCC Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Mangalam Drugs and NCC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mangalam Drugs and NCC

The main advantage of trading using opposite Mangalam Drugs and NCC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, NCC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NCC will offset losses from the drop in NCC's long position.
The idea behind Mangalam Drugs And and NCC Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets